{"id":100,"date":"2021-11-11T15:20:09","date_gmt":"2021-11-11T15:20:09","guid":{"rendered":"https:\/\/obgconnect.com\/senseclinical\/?p=100"},"modified":"2021-11-12T19:09:55","modified_gmt":"2021-11-12T19:09:55","slug":"isuog-recommendations-fetal-ultrasound-follow-up-for-women-with-established-preeclampsia","status":"publish","type":"post","link":"https:\/\/obgconnect.com\/senseclinical\/2021\/11\/11\/isuog-recommendations-fetal-ultrasound-follow-up-for-women-with-established-preeclampsia\/","title":{"rendered":"ISUOG Recommendations: Fetal Ultrasound Follow-Up for Women with Established Preeclampsia"},"content":{"rendered":"\n
The ISUOG Clinical Standards Committee has released practice guidelines reviewing the latest evidence and provides recommendations regarding the role of ultrasound in follow-up for women diagnosed with preeclampsia.<\/p>\n\n\n\n
Ultrasound assessment should include<\/em><\/p>\n\n\n\n Especially in the presence of maternal headache, abdominal pain, bleeding and\/or reduced fetal movements consider<\/em><\/p>\n\n\n\n Note: <\/strong>ISUOG states that the above tests should also \u201cbe considered for women admitted for PE or with suspected PE, as well as for those with severe PE or HELLP syndrome\u201d as a \u2018Good Practice Point\u2019.<\/p>\n\n\n\nRole of Doppler Studies<\/h3>\n\n\n\n
Impact of Medications on Ultrasound Indices<\/h3>\n\n\n\n